# EnteroMedics inks collaborative deal with Galvani Bioelectronics

EnteroMedics inked a collaborative deal with Galvani Bioelectronics, a joint venture between GlaxoSmithKline and Verily Life Sciences, under which Galvani will use a modified vBloc system for pre-clinical research. EnteroMedics will receive payments and retain IP ownership.

- Type: Partnership
- Announced: 2017-07-26
- Where: United States
- Status: completed
- Products: vBloc system, bioelectronic devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [EnteroMedics](https://endata.com/companies/25874.md)
- [GlaxoSmithKline](https://endata.com/companies/5584.md) (investor)
- [Galvani Bioelectronics](https://endata.com/companies/25875.md) (partner)
- [Verily Life Sciences](https://endata.com/companies/25876.md) (investor)

## Sources

- [massdevice.com](https://www.massdevice.com/enteromedics-inks-deal-verily-gsk-jv-galvani-bioelectronics/), 2017-07-26: "EnteroMedics said today it inked a collaborative deal with Galvani Bioelectronics, a joint venture between GlaxoSmithKline and Alphabet's Verily Life Sciences."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.